Internal Medicine, Endocrinology, Diabetes, & Metabolism · Pomona, NY
NPI
1699838870
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
5b Medical Park Dr
Pomona, NY, 10970
Phone (845) 362-3111
Groups this clinician bills Medicare through
Medicare paid, 2024
$314K
23,236 services
Medicare patients, 2024
478
Average age 75
Drug cost, 2024
$1.5M
4,711 prescriptions
Company payments, 2025
$233
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Deborah Raice was code 36415 (venipuncture blood collection), 1,228 times for 444 patients. In total Deborah Raice billed 23,236 services in 80 codes, and Medicare paid $314K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 1,228 | 444 | $8.64 | $11K |
| 99214 Office E&M - Established | Office | 1,098 | 438 | $103.52 | $114K |
| 84443 Clinical Chemistry | Office | 1,096 | 437 | $16.46 | $18K |
| 84479 Clinical Chemistry | Office | 1,080 | 436 | $6.34 | $6,847 |
| 84436 Clinical Chemistry | Office | 1,080 | 436 | $6.73 | $7,268 |
| 80053 Clinical Chemistry | Office | 982 | 421 | $10.32 | $10K |
| 83036 Blood Count | Office | 973 | 421 | $9.50 | $9,244 |
| 83735 Clinical Chemistry | Office | 961 | 416 | $6.56 | $6,307 |
| 85025 Blood Count | Office | 948 | 412 | $7.59 | $7,191 |
| 80061 Clinical Chemistry | Office | 941 | 409 | $13.11 | $12K |
| 82306 Clinical Chemistry | Office | 492 | 370 | $29.01 | $14K |
| 83970 Clinical Chemistry | Office | 385 | 183 | $40.45 | $16K |
| 82043 Clinical Chemistry | Office | 367 | 168 | $5.66 | $2,077 |
| 82570 Clinical Chemistry | Office | 347 | 167 | $5.08 | $1,763 |
| 81000 Clinical Chemistry | Office | 327 | 158 | $3.94 | $1,288 |
By year: 2022 $321K for 22,551 services; 2023 $322K for 22,614 services; 2024 $314K for 23,236 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,228 | 444 | $8.64 | $11K |
| 84443 Clinical Chemistry | 1,096 | 437 | $16.46 | $18K |
| 84436 Clinical Chemistry | 1,080 | 436 | $6.73 | $7,268 |
| 84479 Clinical Chemistry | 1,080 | 436 | $6.34 | $6,847 |
| 80053 Clinical Chemistry | 982 | 421 | $10.32 | $10K |
| 83036 Blood Count | 973 | 421 | $9.50 | $9,244 |
| 83735 Clinical Chemistry | 961 | 416 | $6.56 | $6,307 |
| 85025 Blood Count | 948 | 412 | $7.59 | $7,191 |
| 80061 Clinical Chemistry | 941 | 409 | $13.11 | $12K |
| 82306 Clinical Chemistry | 492 | 370 | $29.01 | $14K |
Medicare prescription drug claims, 2024
In 2024, the drug Deborah Raice prescribed most often to Medicare patients was Levothyroxine Sodium, with 764 prescriptions and refills. In total Deborah Raice wrote 4,711 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 764 | 1,863 | 175 | $11K |
| Synthroid Levothyroxine Sodium | 405 | 1,004 | 94 | $26K |
| Metformin Hcl Er Metformin Hcl | 304 | 744 | 74 | $5,539 |
| Rosuvastatin Calcium Generic | 272 | 726 | 75 | $4,374 |
| Jardiance Empagliflozin | 257 | 514 | 52 | $291K |
| Mounjaro Tirzepatide | 210 | 261 | 34 | $265K |
| Metformin Hcl Generic | 121 | 296 | 29 | $1,011 |
| Atorvastatin Calcium Generic | 104 | 282 | 31 | $828 |
| Amlodipine Besylate Generic | 99 | 297 | 26 | $870 |
| Trulicity Dulaglutide | 96 | 147 | 19 | $137K |
| Januvia Sitagliptin Phosphate | 91 | 209 | 22 | $109K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 84 | 222 | 24 | $13K |
| Ozempic Semaglutide | 80 | 130 | 17 | $114K |
| Novolog Flexpen Insulin Aspart | 64 | 142 | 17 | $15K |
| Lisinopril Generic | 60 | 158 | 15 | $453 |
Brand drugs: 1,972 claims; generic drugs: 2,566 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Deborah Raice $233 ($233 in general payments such as food, travel and fees) from 7 companies. The largest payer was Sanofi-Aventis U.S. LLC with $71.04.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.